Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
Go back to Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR| (NASDAQ: ENSC) | Delayed: 0.28 -0.01 (3.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.29 | 52 Week High | $ | |||
| Open | $0.29 | 52 Week Low | $ | |||
| Day High | $0.29 | P/E | N/A | |||
| Day Low | $0.27 | EPS | $ | |||
| Volume | 417,597 | |||||

